Cargando…

The Role of Exercises in Osteoporotic Fracture Prevention and Current Care Gaps. Where Are We Now? Recent Updates

INTRODUCTION: The primary non-pharmacological management recommended for patients with osteoporosis (OP) is exercise, but whether it should be high-force, resistive, or other means can be obscure. OBJECTIVE: To describe the role of exercises in osteoporotic fracture prevention, identify effects and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senderovich, Helen, Tang, Henry, Belmont, Samuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rambam Health Care Campus 2017
Materias:	New Insights in Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548111/ https://www.ncbi.nlm.nih.gov/pubmed/28786812 http://dx.doi.org/10.5041/RMMJ.10308

Ejemplares similares

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

The tonoplast – where sweetness is dispensable
por: Strasser, Richard
Publicado: (2016)

Where does it come from, where does it go? The role of the xylem for plant CO(2) efflux
por: Gessler, Arthur
Publicado: (2017)

Exercise stress echocardiography: Where are we now?
por: Cotrim, Carlos Alberto, et al.
Publicado: (2022)

Bridging the genotype–phenotype gap in 3D
por: Struik, Paul C.
Publicado: (2016)

Should we undertake surveillance for HCC in patients with MAFLD?
por: Norero, Blanca, et al.
Publicado: (2023)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Update on genetics and epigenetics in metabolic associated fatty liver disease
por: Zhu, Xiaopeng, et al.
Publicado: (2022)

Where are we now?
Publicado: (1977)

Exercise-induced pulmonary hemorrhage: where are we now?
por: Poole, David C, et al.
Publicado: (2016)

Recent progress of immunology research in China
por: Leng, FangWei
Publicado: (2011)

Practicing what we preach for successful interprofessional education
por: Beuken, Juliëtte A., et al.
Publicado: (2021)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

How can we breed for more water use-efficient sugarcane?
por: Ghannoum, Oula
Publicado: (2016)

Partnership working in England—where we are now and where we’ve come from
por: Glasby, Jon, et al.
Publicado: (2011)

One year update on the COVID-19 pandemic: Where are we now?
por: Mishra, Sanjay Kumar, et al.
Publicado: (2021)

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
por: Park, Sang Hyoung
Publicado: (2022)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Cyclin-Dependent Kinase Inhibitors as Marketed Anticancer Drugs: Where Are We Now? A Short Survey
por: Mariaule, Gaëlle, et al.
Publicado: (2014)

An Update on the Ketogenic Diet, 2012
por: Halevy, Ayelet, et al.
Publicado: (2012)

Frailty as an Outcome Predictor After Ankle Fractures: Where Are We Now?
por: Mediouni, Mohamed, et al.
Publicado: (2018)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Double or dual stimulation in poor ovarian responders: where do we stand?
por: Polat, Mehtap, et al.
Publicado: (2021)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Mindfulness in psychiatry – where are we now?
por: Groves, Paramabandhu
Publicado: (2016)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_95q4hr8rhd6vsoa9j8k7cieh6p